Form 4: Quest Diagnostics Director Denise M. Morrison Reports Acquisition and Disposal of Common Stock

Director Denise M. Morrison reports acquisition of restricted share units and disposal of common stock through dividend reinvestment.

Summary

• Denise M. Morrison, a director of Quest Diagnostics Inc., filed a Form 4 detailing changes in beneficial ownership.
• On May 16, 2024, Morrison acquired 1,482 shares of common stock through an award of restricted share units.
• On the same date, Morrison disposed of common stock, the amount of which is not specified, through dividend reinvestment.
• Following these transactions, Morrison beneficially owns 9,490 shares of Quest Diagnostics Inc.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey strong positive or negative sentiment.

Positives

• The acquisition of restricted share units suggests confidence in the company's future performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors to gauge sentiment and potential future actions of key personnel.

Stakeholder Impact

• The transactions may have a minor impact on shareholder sentiment, depending on how investors interpret the director's actions.

Key Dates